A61K 38/162
From virus
Official title: {from virus}
A61K38/162 (From virus) appears on 506 US grants and 929 published applications in this corpus.
Search patents in A61K- Granted patents
- 506
- Published applications
- 929
- Assignees
- 525
- Inventors
- 1,626
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 3 | 0 |
| 1997 | 4 | 0 |
| 1998 | 7 | 0 |
| 1999 | 2 | 0 |
| 2000 | 4 | 0 |
| 2001 | 5 | 6 |
| 2002 | 8 | 22 |
| 2003 | 9 | 32 |
| 2004 | 12 | 25 |
| 2005 | 5 | 32 |
| 2006 | 12 | 35 |
| 2007 | 9 | 26 |
| 2008 | 22 | 33 |
| 2009 | 12 | 38 |
| 2010 | 18 | 35 |
| 2011 | 21 | 51 |
| 2012 | 17 | 24 |
| 2013 | 21 | 44 |
| 2014 | 27 | 46 |
| 2015 | 20 | 45 |
| 2016 | 25 | 42 |
| 2017 | 37 | 45 |
| 2018 | 40 | 33 |
| 2019 | 33 | 43 |
| 2020 | 33 | 41 |
| 2021 | 24 | 54 |
| 2022 | 15 | 50 |
| 2023 | 16 | 34 |
| 2024 | 22 | 39 |
| 2025 | 12 | 29 |
| 2026 | 8 | 25 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Composition for immune tolerance induction and use in gene therapy2 Jun 2026US 12,642,866 B2The Research Foundation for The State University of New York
- Chimeric protein toxins for expression by therapeutic bacteria2 Jun 2026US 12,642,873 B1
- Galectin-targeting immunotherapy26 May 2026US 12,636,341 B2VLP Therapeutics, LLC
- Small extracellular vesicles expressing a dominant negative AMPK alpha 1 mutant for use in the treatment of obesity26 May 2026US 12,637,660 B2Centre National de la Recherche Scientifique (CNRS)
- Therapeutic nanoconjugates comprising Stefin A and uses thereof3 Feb 2026US 12,540,172 B2Consorcio Centro de Investigación Biomédica en Red, M. P.
- Methods and materials for treating cancer8 Oct 2026US 2026/0306566 A1Mayo Foundation for Medical Education and Research
- Peptide compounds to regulate the complement system24 Sep 2026US 2026/0285907 A1Realta Holdings, LLC
- Viral particles with fusogen display and related compositions and methods3 Sep 2026US 2026/0256697 A1Sana Biotechnology, Inc.
- Novel recombinant exosome and use thereof3 Sep 2026US 2026/0256875 A1Shiftbio
- Cpg amphiphiles and uses thereof3 Sep 2026US 2026/0258090 A1Elicio Therapeutics, Inc.
Most cited
By later US patents
- Method for reduction of migraine headache pain225US 5,714,468 A1998
- Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders152US 5,670,484 A1997
- Protective garment for baseball umpires having an inner cushioned layer and an outer layer of interconnected plates66US 5,530,966 A1996
- Method and medicament for inhibiting the infection of influenza virus57US 8,470,771 B2Institute of Microbiology, Chinese Academy of Sciences · 2013
- Atopic dermatitis treatment method51US 6,838,429 B22005